Poxel S.A. (LON:0RA2)
0.2840
-0.0170 (-5.65%)
At close: Feb 11, 2026
Poxel Employees
Poxel had 5 employees as of June 30, 2025. The number of employees decreased by 1 or -16.67% since the number was reported on December 31, 2024.
Employees
5
Change
-1
Growth
-16.67%
Revenue / Employee
1.31M GBP
Profits / Employee
-2.34M GBP
Market Cap
13.20M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 5 | -1 | -16.67% | 5 | 0 |
| Dec 31, 2024 | 6 | 0 | - | 6 | 0 |
| Dec 31, 2023 | 6 | -31 | -83.78% | 6 | 0 |
| Dec 31, 2022 | 37 | -18 | -32.73% | 37 | 0 |
| Dec 31, 2021 | 55 | 5 | 10.00% | 55 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IXICO | 79 |
| Arecor Therapeutics | 44 |
| Oxford BioDynamics | 41 |
| Aptamer Group | 31 |
| Fusion Antibodies | 24 |
| Futura Medical | 14 |
| OptiBiotix Health | 10 |
| Genflow Biosciences | 5 |